Stock price of glaxosmithkline.

See GSK plc (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... GSK plc (GSK) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W ...

Stock price of glaxosmithkline. Things To Know About Stock price of glaxosmithkline.

GSK Historical Data. Assess GSK share price history. View the open price, closing price, historical highs, lows, changes and % change of the GSK plc stock price for the selected range of dates. The data can be viewed in daily, weekly or monthly time intervals. At the bottom of the table you'll find the data summary for the selected range of dates.Discover all the factors affecting GSK's share price. GSK is currently rated as a Neutral | Stockopedia.Dec 1, 2023 · Review the current GSK PLC ADR (GSK:XNYS) dividend yield and history to decide if GSK is the best investment for you. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for GSK plc have a median target of 39.86, with a high estimate of 62.61 and a low estimate of 30.03.

Stock analysis for GSK PLC (GSK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Based on short-term price targets offered by three analysts, the average price target for GSK comes to $40.17. The forecasts range from a low of $35.00 to a high of $45.00. The average price ...

Shares of pharmaceutical company GSK ( GSK 1.41%) -- formerly known as GlaxoSmithKline -- are down 9.4% as of 2:01 p.m. ET Thursday, according to data from S&P Global Market Intelligence, up ...1.21B. -94.01%. Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

The GlaxoSmithKline stock price fell by -0.509% on the last day (Wednesday, 22nd Nov 2023) from $35.38 to $35.20. During the last trading day the stock fluctuated 0.670% from a day low at $35.13 to a day high of $35.37. The price has fallen in 7 of the last 10 days but is still up by 0.4% over the past 2 weeks.Find the latest GSK plc (GLAXF) stock quote, history, news and other vital information to help you with your stock trading and investing. Overview News GSK PLC ADR No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 9.85 ( 11/30/23) EPS (TTM) $3.64 Market Cap $72.42 B Shares …Glaxosmithkline Pharmaceuticals' stock opened at ₹ 1482.6 and closed at ₹ 1461.05 on the last day. The highest price recorded during the day was ₹ 1482.6, while the lowest price was ₹ 1433.95. The market capitalization of the company is ₹ 24,384.3 crore. In the past 52 weeks, the stock has reached a high of ₹ 1622.95 and a low of ₹ 1228.The latest closing stock price for GSK as of November 20, 2023 is 35.11. The all-time high GSK stock closing price was 54.70 on April 13, 2022. The GSK 52-week high stock price is 39.74, which is 13.2% above the current share price. The GSK 52-week low stock price is 33.20, which is 5.4% below the current share price.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Find the latest GlaxoSmithKline (GSK) stock price and news from the BBC. Find the latest GlaxoSmithKline ... Medicines and Healthcare, with GSK. Audio, 57 minutes The Big Green Money Show.

GlaxoSmithKline (GSK.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock GlaxoSmithKline | CINNOBER BOAT: GSK | CINNOBER BOAT. ... GlaxoSmithKline Stock price CINNOBER BOAT Equities GSK GB0009252882 ...3-may, 2023 ... GSK could prove too cheap for all of the near-term uncertainties. Questor says: buy. Ticker: GSK. Share price at close: £14.55. Recommended. The ...About Glaxosmithkline Pharmaceuticals Ltd ... Glaxosmithkline Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs.The site’s GlaxoSmithKline stock forecast for 2025 showed the price ending the year at £14 per share, little changed from £14.02 at the end of this year, then moving down to £13.89 by January 2028. When looking at any GSK stock forecast, you should remember that analysts and algorithm-based forecasters can and do get their …Accordingly, using the consolidation ratio, GSK’s expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected ...Today's highest price of Glaxosmithkline Pharmaceuticals Ltd is ₹1706.25. Today's lowest price of Glaxosmithkline Pharmaceuticals Ltd is ₹1677.85.

The latest closing stock price for GSK as of November 20, 2023 is 35.11. The all-time high GSK stock closing price was 54.70 on April 13, 2022. The GSK 52-week high stock price is 39.74, which is 13.2% above the current share price. The GSK 52-week low stock price is 33.20, which is 5.4% below the current share price.Dec 1, 2023 · GSK's most recent quarterly dividend payment of $0.3613 per share was made to shareholders on Thursday, October 12, 2023. When was GSK's most recent ex-dividend date? GSK's most recent ex-dividend date was Thursday, November 16, 2023. Real time GSK (GSK) stock price quote, stock graph, news & analysis.Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.GSK (GSK) Stock Price Performance. GSK (GSK) ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months.GSK PLC GSK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. ... Prices and Markets > GSK Plc;

As of December 01, 2023, GSK plc (ADR) had a $73.8 billion market capitalization, putting it in the 98th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc (ADR)’s price-earnings ratio is 9.8. GSK plc (ADR)’s trailing 12-month revenue is $37.4 billion with a 22.2% profit margin.GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments.

GSK Plc GSK PLC GSK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentalsGSK (GSK) Stock Price Performance. GSK (GSK) ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months.Complete GSK PLC ADR stock information by Barron's. View real-time GSK stock price and news, along with industry-best analysis. Accordingly, using the consolidation ratio, GSK’s expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected ...Find the latest Ares Capital Corporation (ARCC) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Ares Capital Corporation (ARCC) stock quote, history, news and other vital information to help you with your stock trading and investing.GSK stock fell below the lower boundary of a flat base with a buy point at 36.21, according to MarketSmith.com. Follow Allison Gatlin on X, ... *Real-time prices by Nasdaq Last Sale.Overview News GSK PLC ADR No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 9.85 ( 11/30/23) EPS (TTM) $3.64 Market Cap $72.42 B Shares …

Discover historical prices for GSK.L stock on Yahoo Finance. View daily, weekly or monthly formats back to when GlaxoSmithKline plc stock was issued.

Interactive Chart for GSK plc (GSK), analyze all the data with a huge range of indicators.

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC) for US$14.75 per share of …GSK Plc - ADR (GSK) Dividend Data. Stock Data. Avg Price Recovery. 17.8 Days. Best dividend capture stocks in Nov. Payout Ratio (FWD) 36.05%. Years of Dividend Increase.GSK:LSE price moved over +1.01% to 1,415.20 Nov 30 2023; GSK:LSE price rises above 200-day moving average to 1,426.00 at 08:00 GMT Dec 01 2023; GSK:LSE price rises above 200-day moving average to 1,423.40 at 13:24 GMT Nov 30 2023; GSK:LSE price rises above 15-day moving average to 1,406.60 at 08:00 GMT Nov 30 2023GSK Dividend Information. GSK has an annual dividend of $1.36 per share, with a forward yield of 3.72%. The dividend is paid every three months and the last ex-dividend date was Nov 16, 2023. Dividend Yield. 3.72%.Get the latest GlaxoSmithKline Pharmaceuticals Limited (GLAXO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ... Glaxosmithkline Pharmaceuticals' stock opened at ₹ 1482.6 and closed at ₹ 1461.05 on the last day. The highest price recorded during the day was ₹ 1482.6, while the lowest price was ₹ 1433.95. The market capitalization of the company is ₹ 24,384.3 crore. In the past 52 weeks, the stock has reached a high of ₹ 1622.95 and a low of ₹ 1228.The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq added 0.39%. Prior to today's trading, shares of the dru In the latest trading session, GSK (GSK) closed at $37.10, marking a +1.23% move from the previous day. The stock exceeded the S&P 500, which ...Company Profile. GlaxoSmithKline Egypt S.A.E. specializes in the development, manufacture and marketing of medicines. Their products are for the treatment of diabetes, asthma, cancer, hepatic viruses, infections, allergies and gastro-intestinal and cardiovascular diseases. Sector.

GlaxoSmithKline plc Stock price London Stock Exchange Equities GSK GB0009252882 Pharmaceuticals End-of-day quote London Stock Exchange. Other stock markets. 06:00:00 2021-03-31 pm EDT 5-day change ...Glaxosmithkline Pharmaceuticals stock price went down today, 30 Oct 2023, by -0.34 %. The stock closed at 1435.05 per share. The stock is currently trading at 1430.1 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.Nov 24, 2023 · See the latest GSK PLC stock price (GSK:XLON), related news, valuation, dividends and more to help you make your investing decisions. Get a real-time GSK plc (GSK) stock price quote with breaking news, financials, statistics, charts and more.Instagram:https://instagram. etf for coppervalue of nickelcarro rivian precio3 months treasury yield GSK PLC GSK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals ... Prices and Markets > GSK Plc ... spy options tradingbest stock trading strategy Nov. 16, 2023. In depth view into GSK (GSK) stock including the latest price, news, dividend history, earnings information and financials.GlaxoSmithKline plc (GSK.LON) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock GlaxoSmithKline plc | London Stock Exchange: GSK | London Stock Exchange can you day trade on webull BRITISH AMERICAN TOBACCO PLC ADS Common Stock GBX 2,517.50 BATS0.22% HSBC Holdings plc GBX 604.70 HSBA0.43% Diageo plc GBX 2,812.34 DGE1.77% Relx …GSK shares rose 1.3% on Thursday. RSV is a leading cause of pneumonia in toddlers and the elderly and GSK's shot, branded Arexvy, "will be more than a billion pounds in its first year, (it) has ...